Trusted Resources

AbstractAimsTransthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed cause of heart failure. With a male:female ratio of approximately 10:1, current…

Atrial fibrillation/flutter (AF) is common in transthyretin cardiac amyloidosis (ATTR-CA). The CHARGE-AF score has not been validated in ATTR-CA. The Columbia…

Transthyretin amyloidosis (ATTR) is a condition where a normal protein in the body called transthyretin becomes unstable, forms clumps, and builds up in organs like…

Transthyretin cardiac amyloidosis (ATTR-CM)external link, opens in a new tab is a rare and incurable heart muscle disease. If you have ATTR-CM, proteins accumulate…

Cardiac Amyloidosis ClinicOverviewAt Mayo Clinic, people with symptoms of cardiac amyloidosis receive diagnosis and treatment from a team of experts in the Cardiac…

Dr. Faizi A. Jamal, Chief, Division of Cardiology and Director, Non-Invasive Cardiology Laboratory at the City of Hope National Medical Center has been at the…

AL Amyloidosis: A Real-World Experience with CAR-T Cell TherapyMelinda SY Tan1 , Rahma Warsame1 , Ricardo Parrondo2 , Eli Muchtar1 , Taxiarchis Kourelis1 , Francis…

Key PointsElranatamab elicits deep and rapid heme responses in patients with relapsed AL amyloidosis, including minimal residual disease negativity.No new adverse…

Amyloid light-chain (AL) amyloidosis is the most prevalent type of diagnosed systemic amyloidosis in Western countries, characterized by the deposition of misfolded…

Our patient speakers at the Amyloidosis Speakers Bureau are powerful educators and offer compelling insights. Have a listen to this brief clip from Robert where he…